HugginsC., HodgesC. V.: Studies on prostatic cancer. I: The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer, 1; 293 (1941).
2.
KarrJ. P., WajsmanZ., MadajewiczS.: Steroid hormone receptors in the prostate. J. Urol., 122; 170 (1979).
3.
KarrJ. P., KirdaniR. Y., MurphyG. P.: Androgen binding in the baboon prostate. Arch. Andrai., 2; 123 (1979).
4.
ScottW. W., MenonM., WalshP. C.: Hormonal therapy of prostatic cancer. Cancer, 45; 1929 (1980).
5.
GordonG. C., SouthrenL., TochimotoS.: Effect of medroxyprogesterone acetate on the metabolism and biological activity of testosterone. J. Clin. Endocrin. Metab., 30; 449 (1970).
6.
FangS., LiaoS.: Antagonistic action of antiandrogens on the formation of a specific dihydrotestosterone-receptor protein complex in rat ventral prostate. Molec. Pharmacol., 5; 428 (1969).
7.
BreuerH., HoffmannW.: Wirkungsmechanismus eines Antiandrogens auf die Androgen-Biosynthese. Naturwissensch., 54; 616 (1967).
8.
BagshawM. A.: External radiation therapy of carcinoma of the prostate. Cancer, 45; 1912 (1980).
9.
LubaroffD. M.: Immunologic aspects of the prostate. National Prostatic Cancer Project Workshop in First International Symposium on Prostatic Cancer, Paris, 30.6.1980.
10.
SchmidtJ. D., ScottW. W., GibbonsR.: Chemotherapy programs of the National Prostatic Cancer Project (NPCP). Cancer, 45; 1937 (1980).
11.
MusianiU., BorelliC.: Risultati a distanza della cura femminilizzante del cancro della prostata. Arch. it. Urol., 47; 95 (1975).